Company / EPS (Basic)
GeneDx Holdings Corp. EPS (Basic) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$7.23
FY2025
5-year range
-$264056.00 / -$7.23
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
#152 of 160
Health Care
What the data says
Among 160 Health Care companies, GeneDx Holdings Corp. is in the bottom 5% for eps (basic). Improved from $-53.63 to $-7.23 over the past 2 years.
Based on SEC 10-K filings.
-7.23 in FY2025.
Improved from $-53.63 to $-7.23 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 160This company -$7.23 Sector average $1.67
▼
-532.2% below sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 0.0% year-over-year.
- Ranks #152 out of 160 companies in the Health Care sector.
- Lowest eps (basic) in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$7.23 | +0.0% |
| FY2024 | -$7.23 | +86.5% |
| FY2023 | -$53.63 | +99.9% |
| FY2022 | -$47036.00 | +82.2% |
| FY2021 | -$264056.00 | -461.4% |
| FY2020 | -$47036.00 | +82.2% |
| FY2019 | -$264056.00 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026